Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus–infected persons in the era of highly active antiretroviral therapy

作者: Chunmei C. Wang , Luis C. Yepes , Robert J. Danaher , Joseph R. Berger , Yunanan Mootoor

DOI: 10.1016/J.TRIPLEO.2009.08.037

关键词: Viral sheddingSalivaHerpesviridaeImmunologyVaricella zoster virusHerpes simplex virusVirologyVirusViral diseaseMedicineViral loadSurgeryOral surgeryOtorhinolaryngologyGeneral Dentistry

摘要: Objectives Human herpesviruses, e.g., herpes simplex virus (HSV) type 1, Epstein-Barr virus, and cytomegalovirus, appear in saliva at greater frequency persons infected with human immunodeficiency (HIV) than healthy individuals. However, it is not known if varicella zoster (VZV) HSV-2 simultaneously during HIV infection this era of highly active antiretroviral therapy (HAART). The aim study was to investigate the prevalence amounts VZV HIV-infected orally asymptomatic patients. Study design Quantitative polymerase chain reaction used prevalence, quantity, risk, correlations salivary from 59 HIV-seropositive individuals 53 control subjects a case-control cross-sectional study. Seventy-eight percent patients (46 out 59) were taking HAART. Results DNA detected 5.1% (3 HIV-positive group only 1 1.9% (1 53; P = .62). amount expressors low, generally 1.0). either group. In group, shedding occurred those on HAART, but associated oral lesions, specific CD4 + or CD8 T-cell levels, demographic factors. Conclusions Varicella low persons, whereas cohort. HAART does diminish risk for shedding.

参考文章(49)
B Lönnqvist, O Ringdén, G Lundgren, B Wahren, A Lindholm, H Wilczek, Acyclovir prophylaxis in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases. ,vol. 47, pp. 137- 144 ,(1985)
Cooper Da, Immunological effects of antiretroviral therapy. Antiviral Therapy. pp. 19- 23 ,(1998)
Lawrence Stanberry, Antonio Volpi, Herpes zoster in immunocompromised patients. Herpes. ,vol. 14, pp. 31- ,(2007)
Brian Crucian, Raymond P. Stowe, Duane L. Pierson, Clarence Sams, Satish K. Mehta, Monitoring Immune System Function and Reactivation of Latent Viruses in the Artificial Gravity Pilot Study Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology. ,vol. 14, pp. 21- ,(2007)
C.S. Miller, R.J. Danaher, R.J. Jacob, Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Critical Reviews in Oral Biology & Medicine. ,vol. 9, pp. 541- 562 ,(1998) , 10.1177/10454411980090040901
Kelly A Gebo, Rita Kalyani, Richard D Moore, Michael J Polydefkis, The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. Journal of Acquired Immune Deficiency Syndromes. ,vol. 40, pp. 169- 174 ,(2005) , 10.1097/01.QAI.0000178408.62675.B0
Elizabeth Griffin, Elizabeth Krantz, Stacy Selke, Meei-Li Huang, Anna Wald, Oral mucosal reactivation rates of herpesviruses among HIV‐1 seropositive persons Journal of Medical Virology. ,vol. 80, pp. 1153- 1159 ,(2008) , 10.1002/JMV.21214
Marianne Forsgren, Birgit Sköldenberg, Elisabeth Aurelius, Elena Gille, Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scandinavian Journal of Infectious Diseases. ,vol. 34, pp. 278- 283 ,(2002) , 10.1080/00365540110080485
Juan Pablo Gutierrez, Carlos J. Conde-González, Dilys M. Walker, Stefano M. Bertozzi, Herpes Simplex Virus Type 2 among Mexican High School Adolescents: Prevalence and Association with Community Characteristics Archives of Medical Research. ,vol. 38, pp. 774- 782 ,(2007) , 10.1016/J.ARCMED.2007.04.002
Fujie Xu, Maya R. Sternberg, Benny J. Kottiri, Geraldine M. McQuillan, Francis K. Lee, Andre J. Nahmias, Stuart M. Berman, Lauri E. Markowitz, Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. ,vol. 296, pp. 964- 973 ,(2006) , 10.1001/JAMA.296.8.964